NewDrug is a Research and Development Company that deals with peptide and peptide mimetics synthesis, characterization and identification for Myelin peptide epitopes implicated in multiple sclerosis. Our Chemists are involved in the synthesis of linear and cyclic, MBP, PLP and MOG epitope analogues which are used as immunoregulator agents in Multiple Sclerosis research and work as tools in drug discovery and development of new potent pharmaceuticals.

We can provide services for small to large-sequenced peptide analogues free of by-products identified and characterized in a lyophilized form for biological use only. R&D is the result of pioneer work led by Professors John Matsoukas and Vasso Apostolopoulos.

Myelin Research Networking
Department of Chemistry, University of Patras, Greece
Department of Medicine, University of Patras, Greece
Pasteur Institute, Athens, Greece
Department of Medicine, Aristotle University of Thessaloniki, Greece
College of Health and Biomedicine, Victoria University, Australia

Department of Chemistry, University of Florence, Italy
Department of Biochemistry, University of Tubingen, Germany
Center for Molecular Medicine, Old Dominion, Virginia, U.S.A.
Departments of Chemistry and Pharmacology, University of Cardiff, UK